|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
+4.17% | +9.89% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.97x | 20.32x | 43.14x | 62.15M | ||
| -.--% | -.--% | 18.05x | 1.57x | 0.75x | 11.89x | 12.77x | 15.53B | ||
| -.--% | 0.98% | 21.1x | 2.57x | 1.04x | 16.12x | 16.48x | 7.03B | ||
| 2.05% | 2.41% | 16.55x | 1.73x | 0.72x | 7.5x | 9.44x | 5.78B | ||
| 3.27% | 3.62% | 13.14x | 1.98x | 0.84x | 6.04x | 7.9x | 3.73B | ||
| 3.99% | 4.4% | 16.16x | 7.31x | 0.98x | 7.34x | 10.2x | 3.33B | ||
| 5.67% | 6.29% | 14.59x | 4.37x | 1.23x | 7.51x | 14.56x | 3.26B | ||
| 5.36% | 5.68% | 12.62x | 2.36x | 0.51x | 4.05x | 6.68x | 2.76B | ||
| 1.7% | 2.13% | 24.11x | 4.08x | 0.68x | 8.84x | 14.45x | 1.75B | ||
| 0.08% | -.--% | -49.39x | 2.18x | 0.37x | 14.55x | 206.41x | 1.14B | ||
| 5.64% | 6.34% | 11.74x | 2.36x | 0.86x | 7.05x | 13.3x | 980M | ||
| 4.38% | 4.93% | 11.59x | 0.83x | 0.27x | 2.63x | 5.43x | 918M | ||
| 1.33% | 1.92% | 27.22x | 7.35x | 0.98x | 13.43x | 21.24x | 822M | ||
| 0.39% | 0.4% | 13.41x | 1.87x | 0.65x | 8x | 12.97x | 664M | ||
| Average | 2.6% | 3.01% | 11.61x | 3.12x | 0.85x | 9.66x | 28.21x | 3.41B | |
| Weighted average by Cap. | 1.77% | 2.13% | 15.70x | 2.62x | 0.82x | 10.11x | 16.85x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















